Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20

被引：0
|
作者：
Wasilko, D. [1 ]
Han, S. [1 ]
机构：
[1] Pfizer Inc, Groton, CT USA
来源：
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES | 2020年 / 76卷
关键词：
D O I：
10.1107/S0108767320098529
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：A148 / A148
页数：1
相关论文
共 50 条
  • [31] CCL20及其受体CCR6与消化系肿瘤
    陈伟
    张靖
    朱金水
    现代肿瘤医学, 2018, 26 (24) : 4032 - 4035
  • [32] Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas
    Wang, Liang
    Qin, Huaizhou
    Li, Lihong
    Zhang, Yongsheng
    Tu, Yanyang
    Feng, Fuqiang
    Ji, Peigang
    Zhang, Jingyu
    Li, Gang
    Zhao, Zhenwei
    Gao, Guodong
    MEDICAL ONCOLOGY, 2012, 29 (05) : 3491 - 3497
  • [33] CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice
    Doucet, Michele
    Jayaraman, Swaathi
    Swenson, Emily
    Tusing, Brittany
    Weber, Kristy L.
    Kominsky, Scott L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (07) : 1381 - 1390
  • [34] Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas
    Liang Wang
    Huaizhou Qin
    Lihong Li
    Yongsheng Zhang
    Yanyang TU
    Fuqiang Feng
    Peigang Ji
    Jingyu Zhang
    Gang Li
    Zhenwei Zhao
    Guodong Gao
    Medical Oncology, 2012, 29 : 3491 - 3497
  • [35] Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin
    Gomez-Melero, Sara
    Garcia-Maceira, Fe Isabel
    Garcia-Maceira, Tania
    Luna-Guerrero, Veronica
    Montero-Penalvo, Gracia
    Tunez-Finana, Isaac
    Paz-Rojas, Elier
    BMC BIOTECHNOLOGY, 2021, 21 (01)
  • [36] Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin
    Sara Gómez-Melero
    Fé Isabel García-Maceira
    Tania García-Maceira
    Verónica Luna-Guerrero
    Gracia Montero-Peñalvo
    Isaac Túnez-Fiñana
    Elier Paz-Rojas
    BMC Biotechnology, 21
  • [37] CCL20/CCR6 chemokine signaling is not essential for pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis
    Sachi, Nozomi
    Kamiyama, Naganori
    Saechue, Benjawan
    Ozaka, Sotaro
    Dewayani, Astri
    Ariki, Shimpei
    Chalalai, Thanyakorn
    Soga, Yasuhiro
    Fukuda, Chiaki
    Kagoshima, Yomei
    Ekronarongchai, Supanuch
    Kobayashi, Takashi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 641 : 123 - 131
  • [38] C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release
    Skovdahl, Helene Kolstad
    Damas, Jan Kristian
    Granlund, Atle van Beelen
    Ostvik, Ann Elisabet
    Doseth, Berit
    Bruland, Torunn
    Mollnes, Tom Eirik
    Sandvik, Arne Kristian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [39] CCL20 is a novel ligand for the scavenging atypical chemokine receptor 4
    Matti, Christoph
    D'Uonnolo, Giulia
    Artinger, Marc
    Melgrati, Serena
    Salnikov, Angela
    Thelen, Sylvia
    Purvanov, Vladimir
    Strobel, Tobias D.
    Spannagel, Lisa
    Thelen, Marcus
    Legler, Daniel F.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 107 (06) : 1137 - 1154
  • [40] CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC
    Kallal, Lara E.
    Schaller, Matthew A.
    Lindell, Dennis M.
    Lira, Sergio A.
    Lukacs, Nicholas W.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (04) : 1042 - 1052
12345